CRIS Current Research Information System

GIANNI, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.572
NA - Nord America 1.140
EU - Europa 456
Continente sconosciuto - Info sul continente non disponibili 133
SA - Sud America 70
AF - Africa 40
OC - Oceania 3
Totale 3.414
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.067
VN - Vietnam 565
SG - Singapore 289
CN - Cina 269
IT - Italia 235
HK - Hong Kong 143
BD - Bangladesh 114
KR - Corea 68
CA - Canada 41
FR - Francia 41
BR - Brasile 39
IN - India 31
DE - Germania 28
SE - Svezia 28
NL - Olanda 24
JP - Giappone 23
FI - Finlandia 20
GB - Regno Unito 17
TH - Thailandia 14
CI - Costa d'Avorio 13
IE - Irlanda 13
PH - Filippine 13
AT - Austria 10
SC - Seychelles 10
RU - Federazione Russa 9
JM - Giamaica 8
AR - Argentina 7
ID - Indonesia 7
CL - Cile 6
CR - Costa Rica 6
GH - Ghana 6
MX - Messico 6
CH - Svizzera 5
JO - Giordania 5
CO - Colombia 4
EC - Ecuador 4
LT - Lituania 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
VE - Venezuela 4
AU - Australia 3
BE - Belgio 3
BG - Bulgaria 3
BO - Bolivia 3
ES - Italia 3
IQ - Iraq 3
PK - Pakistan 3
RO - Romania 3
TG - Togo 3
ZA - Sudafrica 3
EE - Estonia 2
GY - Guiana 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PL - Polonia 2
SA - Arabia Saudita 2
TR - Turchia 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AZ - Azerbaigian 1
BM - Bermuda 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LC - Santa Lucia 1
MA - Marocco 1
MD - Moldavia 1
MG - Madagascar 1
MM - Myanmar 1
MT - Malta 1
NG - Nigeria 1
PY - Paraguay 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UA - Ucraina 1
VG - Isole Vergini Britanniche 1
Totale 3.283
Salva come PNG Salva come JPEG
Città #
Singapore 218
San Jose 205
Ho Chi Minh City 152
Hanoi 137
Ashburn 132
Hong Kong 131
Hefei 118
Council Bluffs 97
Seoul 59
New York 49
Los Angeles 44
Bologna 43
Santa Clara 36
Lauterbourg 22
Da Nang 21
Chicago 17
Haiphong 17
Milan 17
Tokyo 15
Beijing 14
Buffalo 14
Dallas 14
Abidjan 13
Boardman 13
Princeton 13
Rome 13
Dublin 12
São Paulo 12
Bengaluru 11
Ha Long 10
Helsinki 10
Hải Dương 10
Lappeenranta 10
Modena 10
Thái Nguyên 9
Amsterdam 8
Biên Hòa 8
Bắc Giang 8
Toronto 8
Frankfurt am Main 7
Miami 7
Accra 6
Bangkok 6
Charlotte 6
Vienna 6
Can Tho 5
Casalecchio di Reno 5
Chandler 5
Des Moines 5
Hangzhou 5
Jakarta 5
Montreal 5
Philadelphia 5
Quận Bình Thạnh 5
San Lazzaro di Savena 5
Thái Bình 5
Điện Bàn 5
Amman 4
Atlanta 4
Brooklyn 4
Castel Maggiore 4
Cleveland 4
Florence 4
Houston 4
Mexico City 4
Millington 4
Quận Phú Nhuận 4
Ravenna 4
Reggio Emilia 4
Simpsonville 4
Southend 4
Vũng Tàu 4
Abbeville 3
Baghdad 3
Bari 3
Bắc Ninh 3
Caracas 3
Catania 3
Delhi 3
Elk Grove 3
Freudenberg 3
Georgetown 3
Guangzhou 3
Hyderabad 3
Indianapolis 3
Kingston 3
La Paz 3
Lomé 3
Long Xuyen 3
Marseille 3
Monzuno 3
Munich 3
Nha Trang 3
Ninh Bình 3
North Kansas City 3
Nuremberg 3
Paris 3
Pembroke 3
Phủ Lý 3
Quận Sáu 3
Totale 1.992
Salva come PNG Salva come JPEG
Nome #
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants 367
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer 197
Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical Implications 166
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure 162
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives 161
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma 147
Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1) 141
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients 113
Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy 110
Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial 103
Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives 101
An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA 99
Recurrent pneumothorax in a patient with liposarcoma as either a complication of lung micrometastasis or a potential adverse event from antibiotic therapy: A case report 95
Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors 85
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer 79
ROLE OF HPV VACCINATION AFTER CARCINOMA IN SITU OF CERVIX UTERI (CIN) IN REAL-WORLD PATIENTS 73
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions 72
Impact of circulating tumor DNA (ctDNA) surveillance on clinical care for patients with stage I-III breast cancer: Findings from a multi-institutional study 71
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 69
Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study 65
Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer 64
Mapping breast cancer therapy with circulating tumor cells: The expert perspective 59
Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma 52
Circulating tumor DNA detection of local recurrence in a patient with early stage triple-negative breast cancer 52
Investigating biochemical markers of Acupuncture's effectiveness in managing climacteric syndrome in breast cancer patients: the FLAIR study 50
Case Report: Circulating Myeloid-Derived Suppressive-Like Cells and Exhausted Immune Cells in Non-Small Cell Lung Cancer Patients Treated With Three Immune Checkpoint Inhibitors 49
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer 47
Artificial intelligence for predicting pathological complete response to neoadjuvant therapy in triple-negative breast cancer: A systematic review and meta-analysis 46
Inflammatory indexes as prognostic biomarkers in advanced triple negative breast cancer patients 43
Multiparametric whole-body magnetic resonance imaging in breast cancer management: A prospective study 43
Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer 40
Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer 39
Corrigendum to “Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives” [Crit. Rev. Oncol./Hematol. 181 (2023) 103900] (Critical Reviews in Oncology / Hematology (2023) 181, (S1040842822003249), (10.1016/j.critrevonc.2022.103900)) 39
Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer 37
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysis 36
Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates 34
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine 34
Elucidating PI3K/AKT/PTEN Pathway Alterations at Single-Cell Level in CTCs From HR+/HER2− Metastatic Breast Cancer 29
Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic Review 29
Adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: one fits all? 28
Corrigendum to “Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond” [Crit. Rev. Oncol./Hematol. 200C (2024) 104404](S1040842824001471)(10.1016/j.critrevonc.2024.104404) 28
Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors 23
Surgical Management of Early-Onset Breast Cancer Among Young BRCA1 and BRCA2 Carriers 13
Combining circulating tumor cells and tumor-derived extracellular vesicles for prognosis stratification in patients with metastatic breast cancer 12
Association between type and location of germline BRCA1/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort study 11
Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options 1
Totale 3.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.181
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202239 0 0 0 3 1 1 5 2 0 7 13 7
2022/202341 3 5 1 4 4 2 3 1 10 1 2 5
2023/202442 2 3 0 0 2 5 7 5 8 9 0 1
2024/2025293 17 22 24 24 24 15 7 12 9 21 33 85
2025/20262.237 321 139 95 80 70 26 323 113 517 207 183 163
2026/2027762 86 162 229 285 0 0 0 0 0 0 0 0
Totale 3.414